Abortion pill complications are underreported, report finds  

CNA Staff, Sep 24, 2025 / 06:00 am

Abortion pill complications go underreported in abortion industry studies and mainstream media, according to a recent report by the National Right to Life Committee (NRLC).

Abortion industry studies claim that serious complications are incredibly rare — occurring in less than half a percent of cases, according to the report “Missed, Misclassified, and Minimized: Why Abortion Pill Complications Are Underreported.”

But a study last year found that more than 1 in 10 women who took the abortion pill experienced serious complications such as hemorrhaging, infection, failed abortions, and surgical follow-up.

The author of the report, Randall O’Bannon, set out to investigate the discrepancy.

O’Bannon, director of education and research for the National Right to Life, found several factors contributing to the discrepancies. For one, he found that abortion providers often encourage women to conceal negative side effects and tell doctors they are symptoms of a miscarriage. O’Bannon also observed what he called a “contemptible lack of curiosity in the media” toward stories of women hurt by abortion drugs. Finally, serious complications are often categorized as “minor,” O’Bannon found.

O’Bannon said the “flawed or slanted industry studies” are “not good enough.”

“The public — and policymakers — deserve accurate, transparent reporting on the dangers of chemical abortion,” he said in a statement.

Dr. Ingrid Skop, vice president and director of medical affairs for Charlotte Lozier Institute and a board-certified OB-GYN, said she has encountered these medical complications in her own career as a medical provider.

“I have cared for dozens of women presenting to the ER with abortion drug complications, and they are told by abortion advocates there’s no need to report the use of abortion drugs,” she told CNA.

“When I see a woman in the ER with continued pain and bleeding sometimes weeks or even months after taking abortion drugs, she usually has retained pregnancy tissue and/or the dead baby, which the drugs have failed to expel,” Skop continued. “An unaware ER doctor is likely to give her more of the drugs that already failed rather than expediting the surgical aspiration she needs.”

“As a researcher and practicing OB-GYN, I can attest that the lived experience for many women reflects the data documented in this report,” Skop said.

“So where are all the women some of these later reports and studies say have been injured and abused by these drugs and their prescribers?” O’Bannon asked. “Once again, we see that they have been silenced and minimized, told their pain and blood and trauma are ‘minor complications’ that somehow just don’t rise to the level worthy of being noticed. But they suffer and bleed just the same.”

Looking at the numbers  

Michael New, assistant professor of practice at the Busch School of Business for The Catholic University of America, noted that “the FDA’s own data shows that there are a number of health risks involved with chemical abortions.”

“Since the FDA approved the chemical abortion pill in 2000, the FDA’s own data indicates that there have been 32 deaths, 4,218 adverse events, 1,049 hospitalizations, 604 cases of blood loss requiring a transfusion, 418 infections, and 75 severe infections,” New, a senior associate scholar at the Charlotte Lozier Institute, told CNA. 

The FDA figures “are underreported” due to a change in the reporting requirements implemented nearly a decade ago, according to New.

(Story continues below)

Subscribe to our daily newsletter

“In 2016, the FDA quit requiring that health care professionals report complications from chemical abortion drugs,” New said. “Since 2016, the reporting of complications has been voluntary.” 

In 2020, during the COVID-19 pandemic, the FDA removed the requirement for women to have an in-person medical exam before being prescribed chemical abortion drugs.

Since then, “the number of complications has almost certainly increased,” New said.

Without a medical exam, abortion providers may unwittingly provide abortion drugs to women whose pregnancies are further along than is recommended for chemical abortions, as well as women who have ectopic pregnancies (a life-threatening condition where the embryo implants outside the uterus). 

Trump administration continues to implement ‘unwise policy’

“The Biden administration FDA and thus far the Trump administration FDA have continued with this unwise policy,” New said. 

Chemical abortions are sometimes falsely advertised as “safer than Tylenol.” But a chemical abortion is far less safe than even a surgical abortion, Skop noted. 

“Complications occur at least four times as frequently following drug-induced abortions compared to surgical abortions, causing at least 1 in 15 women to require emergency care when the drugs are used as the FDA recommends,” Skop said. “Even more women suffer when they are taken at advanced gestational ages.” 

“The abortion pill is being sold as safe, but independent data tell another story,” Carol Tobias, president of National Right to Life, said in a statement. “Women are being harmed, and the dangers are being ignored or hidden.” 

“Abortion industry spin makes mifepristone abortions sound easy, but the truth is each abortion takes the life of a living preborn child and places the woman in danger,” Tobias said.

How can policymakers respond?

New noted that public officials could take several steps “to protect mothers and children” from these dangers, including requiring that “medical professionals report complications that arise from chemical abortions.” 

In addition, the FDA “could require that women obtaining chemical abortions first have an in-person medical exam,” a change that New said the Trump administration could make “right away.” 

“Thus far, it is disappointing that the Trump administration has not prioritized keeping women safe from unregulated chemical abortion drugs,” New said. 

Skop added that “policymakers need better abortion data.” 

“Extensive deficiencies affect abortion data collection in the U.S., including a lack of anonymized national reporting requirements,” Skop said. 

“Women also need to know the true risk of abortion and potential complications, which are both physical and mental,” she continued. 

Skop noted that “the majority of women with a history of abortion would have preferred to give birth if they had the necessary support.” 

“Women also should know there are 2,750 pregnancy resource centers that want to walk alongside women facing an unintended pregnancy to provide any support they need,” Skop said. 

Nonprofit organizations across the country exist to provide pregnant women and mothers with support — from baby clothes to ultrasounds to parenting classes. 

“The abortion industry’s goal is to promote all-trimester abortion on demand,” Skop noted. “And lawmakers, the public, and most importantly, women considering abortion, must understand abortion advocates will mislead them to achieve that goal.”